Payers and providers play an important role in addressing the opioid crisis in our communities. This page highlights the most recently added resources specifically targeting healthcare providers, healthcare system employees, and individuals who manage private and public insurance plans. These resources, identified with blue tiles, include patient and provider education materials, clinical practice guidelines and practice protocols, and research and reports about insurance coverage and benefit design around addiction treatment and pain management.
If you’d like to submit materials for inclusion consideration or suggest a future featured topic, please visit CLOUD’s call for submissions page.
This is the website for the Arizona enhanced opioid surveillance data project. It provides real time data on a variety of opioid topics including overdose, use of naloxone, neonatal withdrawal syndrome (or neonatal abstinence syndrome), and reports based on age, gender, and geographic location.
In 2018, Arizona published curriculum on pain and addiction to be used in undergraduate, graduate and continuing medical education. The state is now in the process of developing a curriculum on pain and addiction to be used in medical residency settings. This is the website for the curriculum development initiative.
Arizona’s Opioid Action Plan recommended that the health education providers in the state create a statewide curriculum for all prescribers about pain and addiction. This is the website for the curriculum which provides background information, provides notices of upcoming developments, and provides links to the curriculum. The curriculum is free and available to be adopted nationwide. It is also included in the CLOUD library for review or download.
Arizona’s government adopted legislation requiring all Arizona providers to electronically prescribe any Schedule II controlled substance by January 1, 2020. This website is the home of the Electronic Prescribing of Controlled Substances (EPCS) program and includes information and
The Arizona State Public Health Laboratory has created a program to screen blood samples from individuals with a suspected opioid overdose in order to better understand which opioids are responsible for causing overdoses in the state. Health care providers and institutions can request a courier to pick up samples which are then tested for the qualitative identification of opioids, fentanyl analogs, benzodiazepines, stimulants, cannabinoids, and synthetic cannabinoids. This is the Arizona Department of Health Services website for the laboratory testing program.
This Arizona Department of Health Services website includes information about the state’s various initiatives to encourage naloxone distribution and administration to reverse opioid overdoses. It includes links to documents, patient brochures, sample policies and training programs for law
This website provides access to Arizona’s free online continuing medical education (CME) program for healthcare professionals. Educational topics include Arizona’s opioid laws and regulations, prescribing guidelines, and treatment options including medication assisted treatment for opioid use disorder.
This fact sheet lists resources with information about naloxone and includes links to important web sites. Part of the Arizona ReThink RX Abuse initiative which helps communities educate their citizens about prescription drug safety.
A step-by-step guide for providers, patients, or caregivers on how to use the Substance Abuse and Mental Health Service Administration’s Behavioral Health Treatment Locator. Part of the Arizona ReThink RX Abuse initiative which helps communities educate their citizens about
This two page fact sheet explains the two pre-screen questions and the Drug Abuse Screening Test (DAST) health care providers can use when administering a Screening, Brief Intervention and Referral to Treatment (SBIRT) assessment. Part of the Arizona ReThink RX Abuse initiative,